Real Stories
18 Jul 2025

The facts, the figures and the stories: making an impact for men in 2024/25

With your support, we've impacted the lives of millions more men over the last year. But what exactly did we achieve? Find out how we're moving closer to a world where no man dies of prostate cancer.

Over the last 12 months, prostate cancer has captured people's attention like never before - with high-profile celebrities like Sir Chris Hoy stepping forward to share their diagnosis and incredible partners like Omaze and Paddy Power joining forces with us to help save men's lives.

Together we've made big progress in getting more men diagnosed early, shaping a faster and fairer health system, and giving men more time to do the things they enjoy with the people who matter most to them.

Our brand new Impact Report sets out what we've achieved together in the last year. It's the story of your support.

Dave & Pete 4 (1)
After his brother Pete's prostate cancer diagnosis, Dave Cossie acted quickly to get tested

Helping more men find prostate cancer early

'Knowing my risk turned out to be a lifesaver'

Prostate cancer is the most common cancer in men. But despite this, there's still no screening programme inviting men for regular tests to help find it early. And that means there are still far too many men being diagnosed when it's too late. But thanks to your support this year, we're leading the way towards a better future for men.

After his twin brother Pete was diagnosed with stage four prostate cancer, Dave Cossie knew their Caribbean heritage and family history of the disease meant he was at higher risk. He got checked - and because he found his cancer early, he had treatment options. Thanks to your support, more men like Dave are finding prostate cancer early. 

1.5 million more men have taken our quick and easy online Risk Checker

That’s more than we’ve ever seen in a single year. And we’ve continued to raise awareness among men at greatest risk. As a result, hundreds of thousands more men have found out they’re at higher risk and been empowered to talk to their GP about having a PSA blood test. 

As well as raising awareness, we also need to improve the way we diagnose the disease. That’s where the research we fund comes in.

Speeding up diagnosis and paving the way to a screening programme

Research like the PRIME trial, which has showed that a streamlined MRI scan can be just as effective at finding prostate cancer as the current gold standard – and faster. Taking around a third less time, the new scans could bring down waiting times for men and make MRI scans cheaper and more readily available. 

The faster scans will be tested as part of our £42 million TRANSFORM trial to help find the best way to diagnose prostate cancer. TRANSFORM will pave the way to a national screening programme where men are invited for regular accurate tests to find prostate cancer early.    

202504 Parliament Campaign Letter Gem Huntingford 64
In April we presented our letter to the Health Secretary, calling for changes to outdated GP guidelines

Faster, fairer, better: shaping a health system that works for every man

Pushing ministers to take urgent action on prostate cancer

We know some men are at higher risk than others - and our health system is letting them down. That's why, through our Faster Fairer Better campaign, we're using our growing influence to make sure every man gets the best possible treatment, care and support. 

We want to see the Government take urgent action, including changing outdated NHS guidelines to empower GPs to talk about prostate cancer with Black men and men who have a family history of prostate cancer from the younger age of 45. As a result of our campaigning:

Giving men more time, thanks to pioneering research

'We're hopeful the treatment will mean we can enjoy more quality time together'

In February 2023, John Flanagan was diagnosed with advanced, aggressive prostate cancer. As his cancer spread up his spine, John's hormone therapy stopped working. He became virtually immobile, taking strong medication to manage his pain. But since then, a mix of other treatments has completely eliminated the pain and restored his mobility.

Thanks to your support, we're funding research to pioneer new and better treatments that will give men with advanced prostate cancer, just like John, more time with their loved ones. 

Today we have 60 active research projects – including the TRAP trial - which has shown that a type of targeted radiotherapy, alongside hormone therapy, could offer precious extra time for men with advanced prostate cancer.

Men who took part in the trial gained an average of six extra months in which their cancer didn't progress. And for over 40 per cent of the men, their cancer showed no progression at all after a year.

202411 Spring DM 2025 Sharon And John Rosie Lonsdale 14 (1)
John Flanagan, pictured with his wife Sharon, has benefited from life-extending treatments driven by research

... and we’ve always got the time to talk

With your help, we've been there to support thousands of men and their loved ones as they navigate prostate cancer. That includes:

 

Dig deeper into the impact you’ve made for men this year

Feeling inspired? Click the button below to discover more about the impact of your support in 2024/25.

DISCOVER YOUR IMPACT

202010 George Seed Researcher

How our research is making a difference

Over the last 25 years, our research, funded by supporters like you, has changed the lives of men with prostate cancer. From transforming the way prostate cancer is diagnosed to developing the first precision medicine for advanced prostate cancer, we've made this happen together.
The impact of research